Introduction
Thalassemia is the most common hereditary disorder in the world including Bangladesh. The thalassemias are a major health problem all over the world, but this is particularly in the developing countries where the resources are limited 1, 2 . Prevalence of both beta thalassemia trait and Hb E trait is significantly high in Bangladesh and thalassemia will be a major genetic problem in the coming years 3 . As a wide spectrum of clinical phenotypes have been observed in various forms of Hb E disorders, this prompted us to present the clinico-hematological findings of our patient and her family for comparative evaluation 4 . It is also important to know the carrier status of haemoglobin disorder in a country to form the basis for future planning for the control of thalassemia.
Case Report
The patient was a 50-year old Bangladeshi female who presented with symptoms of general malaise and dizziness for the last 5 years and was found mildly anemic and non icteric without any hepatosplenomegaly or lymphedonopathy. She was postmenopausal, normotesive and had normal bowel and bladder habit. To conclude the pedigree of the family, father of offspring was investigated and found Hemoglobin E trait. He was also clinically asymptomatic. All the hematological indices & electrophoretic findings of our patient and other family members are presented in [ Table 1 ]. Individuals with the Hb E Trait is usually not anemic and have no symptoms. Hematological investigations of these individuals reveal mild microcytosis, hypochromia and erythrocytosis. However, identification of these individuals is of crucial importance as they may be transmitters of the abnormal gene, giving rise to various combinations of hemoglobinopathies and thalassemias in their progeny. The presentation of Hb E disease is mild to moderate. Most patients show clinical symptoms by the age of 10 years. The most common presentation of Hb E disease is no or mild anemia, jaundice, fever, abdominal pain and gastrointestinal disturbances with or without Splenomegaly. The blood picture shows microcytic hypochromic red cells with or without any evidence of hemolysis 6 . These new insights into the knowledge of these diseases are important because they are gradually becoming global health problems and impart diagnostic challenges to all the experts involved in the treatment of patients with thalassemia.
Conclusion
The main aim is to increase the awareness of this hemoglobin disorder, so that it can be included in the differential diagnosis of patients presenting clinically like thalassemia intermedia or thalassemia major. This awareness may also help in genetic counseling and clinical management. Awareness, mass screening programme and genetic counseling should be started immediately along with facilities for prenatal diagnosis to prevent the births of thalassemic children. 
